Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Neurosterix US Holding LLC
Delaware, USA
We hereby consent to the incorporation by reference in in the Prospectus constituting a part of this Registration Statement of our report dated May 15, 2025, relating to the Neurosterix US Holding LLC consolidated financial statements appearing in Addex Therapeutics Ltd’s Annual Report on Form 20-F for the year ended December 31, 2024.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
| BDO AG | ||
| /s/ Nigel Le Masurier | /s/ Philipp Kegele |
Zurich, November 19, 2025